Chengde Z. Yang

No. 197 Ruijin Second Road
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Association of transferrin levels with clinical outcomes in ANCA-associated vasculitis.

Association of transferrin levels with clinical outcomes in ANCA-associated vasculitis.

Journal: Clinical rheumatology

Published: December 30, 2025

Single high-dose intramuscular injection versus short-term low-dose oral glucocorticoids as bridging therapy in active rheumatoid arthritis: a retrospective cohort study on remission induction.

Single high-dose intramuscular injection versus short-term low-dose oral glucocorticoids as bridging therapy in active rheumatoid arthritis: a retrospective cohort study on remission induction.

Journal: Clinical rheumatology

Published: September 10, 2025

Glycosylation of anti-dsDNA IgG correlates with organ involvement in treatment-naïve patients with systemic lupus erythematosus.

Glycosylation of anti-dsDNA IgG correlates with organ involvement in treatment-naïve patients with systemic lupus erythematosus.

Journal: Lupus science & medicine

Published: May 12, 2025

EULAR and PReS bridge the age gap in Still's disease.

EULAR and PReS bridge the age gap in Still's disease.

Journal: Nature reviews. Rheumatology

Published: November 25, 2024

Correction: Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.

Correction: Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.

Journal: BMC medicine

Published: October 15, 2024

Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.

Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.

Journal: Journal of autoimmunity

Published: November 10, 2023

Risk factors in antiphospholipid antibody-associated valvular heart disease: A 383-patient cohort study.

Risk factors in antiphospholipid antibody-associated valvular heart disease: A 383-patient cohort study.

Journal: Clinical immunology (Orlando, Fla.)

Published: August 07, 2023

Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.

Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.

Journal: BMC medicine

Published: August 07, 2023

The use of high-sensitivity cardiac troponin I in assessing cardiac involvement and Disease prognosis in idiopathic inflammatory myopathy.

The use of high-sensitivity cardiac troponin I in assessing cardiac involvement and Disease prognosis in idiopathic inflammatory myopathy.

Journal: Advances in rheumatology (London, England)

Published: April 04, 2023

Neutralizing anti-IFN-γ IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection.

Neutralizing anti-IFN-γ IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection.

Journal: Clinical rheumatology

Published: March 15, 2023

CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis.

CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis.

Journal: Nature communications

Published: March 03, 2023

Performance of the modified Systemic Manifestation Score for systemic juvenile idiopathic arthritis in Adult-onset Still's disease.

Performance of the modified Systemic Manifestation Score for systemic juvenile idiopathic arthritis in Adult-onset Still's disease.

Journal: Clinical rheumatology

Published: April 26, 2022

Showing 1-12 of 62

Last Updated: 09/26/2026